Clinical trial
The Registry to Observe Clinical Outcomes of Patients With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
NCT04034095 is registered in ClinicalTrials.gov with Janssen Pharmaceutical K.K. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Registry to Observe Clinical Outcomes of Patients With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
- Lead sponsor
- Janssen Pharmaceutical K.K.
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 8, 2019
- Completion date
- August 13, 2024
- Enrollment
- 979 (actual)
- Sites
- 77
Conditions
As the registry lists them; a condition with its own page is linked.